Trump signs executive order slashing prescription drug costs by up to 80%
- President Donald Trump signed an executive order on Monday, May 12, 2025, at the White House to reduce prescription drug costs in the United States.
- This order revives Trump’s previous failed effort to implement a 'most favored nation' policy that sets Medicare Part B drug prices equal to the lowest prices paid globally by other advanced countries.
- The policy instructs the Health and Human Services agency to base Medicare reimbursements for physician-administered drugs—such as cancer treatments given by infusion or injection—on the lowest prices paid in other countries, while excluding most typical prescriptions dispensed through pharmacies.
- Trump claimed the plan will save 'TRILLIONS OF DOLLARS' and lower healthcare costs 'by numbers never even thought of before,' although experts suggest these savings may be exaggerated and the policy faces strong pharmaceutical industry opposition.
- If implemented, the order could reduce Medicare drug spending, which topped $33 billion in 2021, but long-standing challenges and legal barriers, including prior court blocks, suggest the policy’s future impact remains uncertain.
488 Articles
488 Articles
'All hat and no cattle': Democrats call Trump's bluff on drug price Executive Order
If U.S. President Donald Trump actually wants to curb out-of-control prescription drug prices, he'll throw his support behind legislative efforts instead of trying to do so unilaterally—an approach that's unlikely to survive legal challenges. That was the message that Sen. Bernie Sanders (I-Vt.) and congressional Democrats sent to the White House after Trump signed an executive order Monday aimed at pushing "pharmaceutical manufacturers to bring…

Trump signs order aiming to lower U.S. drug costs to match prices abroad
A pharmacy manager retrieves a bottle of antibiotics. (Photo by Joe Raedle/Getty Images)WASHINGTON — President Donald Trump signed an executive order Monday aimed at lowering drug prices by pressuring pharmaceutical companies to align their U.S. pricing models with those in similarly wealthy countries. “We’ll slash the cost of prescription drugs and will bring fairness to America,” Trump said at a morning White House event. “We’re all gonna pay …
Coverage Details
Bias Distribution
- 51% of the sources are Center
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage